share_log

Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care

Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care

破解密码:了解分析师对 Tandem 糖尿病护理的评论
Benzinga ·  04/23 15:01
Ratings for Tandem Diabetes Care (NASDAQ:TNDM) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中,有5位分析师提供了Tandem Diabetes Care(纳斯达克股票代码:TNDM)的评级,显示了看涨和看跌的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级,简要介绍了过去30天中不断变化的情绪,并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.0, a high estimate of $40.00, and a low estimate of $24.00. This current average has increased by 26.87% from the previous average price target of $26.80.
分析师分析的12个月目标股价提供了见解,平均目标价为34.0美元,最高估计为40.00美元,低估值为24.00美元。目前的平均价格较之前的26.80美元的平均目标股价上涨了26.87%。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级:详细审查
The standing of Tandem Diabetes Care among financial...
通过对分析师近期...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发